SCHEMBL6780265

SCHEMBL6780265

FC(F)(F)c1cccc(C2CN(C(c3ccccc3)c3ccccc3)C2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.50
OPRD1 P41143 3/20 0.50
OPRK1 P41145 3/20 0.50
OPRL1 P41146 3/20 0.50
GRIN2B Q13224 1/20 0.50
SLC6A9 P48067 1/20 0.49
HTR2C P28335 2/20 0.49
CACNA2D1 P54289 1/20 0.47
CACNA1B Q00975 1/20 0.47
CACNB1 Q02641 1/20 0.47
CACNA1C Q13936 1/20 0.47
CHRM2 P08172 1/20 0.45
HTR1A P08908 1/20 0.45
DRD3 P35462 1/20 0.45
HTR2B P41595 1/20 0.45
DRD2 P14416 1/20 0.45
HSD17B2 P37059 1/20 0.43
SLC6A4 P31645 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6774667 0.84 OPRM1 (0.50) OPRM1OPRD1OPRK1OPRL1GRIN2B
SCHEMBL17048566 0.82 GRIN2B (0.42) OPRM1OPRD1OPRK1OPRL1GRIN2B
SCHEMBL13018937 0.81 DRD3 (0.61) GRIN2BHTR2CCHRM2HTR1ADRD3
SCHEMBL1740290 0.79 OPRM1 (0.47) OPRM1OPRD1OPRK1OPRL1SLC6A9
SCHEMBL72584 0.77 SLC6A2 (0.50) OPRM1OPRD1OPRK1OPRL1SLC6A9
SCHEMBL13063397 0.75 DRD2 (0.58) HTR2CCHRM2HTR1ADRD3HTR2B
SCHEMBL11727598 0.75 OPRL1 (0.62) OPRM1OPRD1OPRK1OPRL1GRIN2B
SCHEMBL4636128 0.75 SLC6A9 (0.50) OPRM1OPRD1OPRK1OPRL1SLC6A9
SCHEMBL4635535 0.74 TACR1 (0.54) OPRM1OPRD1OPRK1OPRL1SLC6A9
SCHEMBL25121942 0.72 HTR2C (0.56) HTR2CHTR1AHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6831078-B1 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant VERNALIS RESEARCH LIMITED (GB) 2004-12-14 US disclosed
EP-1049670-B1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RES LTD (GB) 2002-07-17 EP disclosed
EP-1196165-A2 AZETIDINE COMPOUNDS IN CNS AND EYE DISEASES VERNALIS RESEARCH LIMITED (GB) 2002-04-17 EP disclosed
WO-2001007022-A2 AZETIDINE COMPOUNDS IN CNS AND EYE DISEASES VERNALIS RESEARCH LIMITED (GB) 2001-02-01 WO disclosed
EP-1049670-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 2000-11-08 EP disclosed
WO-1999037613-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 1999-07-29 WO disclosed